DMD &amp; BMD – CLINICAL

Szabo, S; Audhya, Ivana F.; Malone, DC; Neumann, Paul E.; Feeny, David; Harwood, M.; Gooch, KL

doi:10.1016/j.nmd.2020.08.064

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This large variance could be due to the small sample size, i.e., 20. According to previous studies, sample size is one of the main criteria for quality assessment and is generally judged based on whether the sample size is 100 or more (Papaioannou et al, 2013;Meregaglia and Cairns, 2017;Szabo et al, 2020).…”

Section: Discussionmentioning

confidence: 99%

“…To our knowledge, there are no agreed-upon reporting standards for HSUV studies. Therefore, the quality of the included studies was evaluated using the criteria framework set described by Papaionannou et al (Papaioannou et al, 2013), which was used in previous studies (Meregaglia and Cairns, 2017;Saeed et al, 2020;Szabo et al, 2020). The criteria were as follows: 1) sample size ≥100; 2) description of respondent selection and recruitment; 3) description of inclusion/exclusion criteria; 4) response rate ≥60%; 5) reporting of the amount and reasons for loss to follow-up; 6) reporting of the level of missing data and methods to handle the issue; and 7) appropriateness of the measure (based on the judgment of the review authors).…”

Section: Quality Assessmentmentioning

confidence: 99%

See 1 more Smart Citation

Health-related quality of life in adult patients with asthma according to asthma control and severity: A systematic review and meta-analysis

Lee

Nam

et al. 2022

Front. Pharmacol.

View full text Add to dashboard Cite

Background: The utility values are increasingly being used in economic evaluations and health policy decision making. This study aims to conduct a systematic literature review and meta-analysis of the utility values for asthma, particularly with respect to severity and asthma control.Materials and methods: A literature search was conducted using the MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases for studies published until July, 2020, reporting the utilities of adult asthma. We extracted utility values derived by nine indirect and four direct utility instruments. Meta-analyses were performed for each utility instrument according to health states based on the level of asthma control and severity.Results: Fifty-two eligible studies were included in our systematic review, of which forty studies were used in the meta-analyses. Among the 13 utility instruments, the most used was EQ-5D-3L, whereas EQ-5D-5L showed the narrowest 95% confidence interval (95% CI, 0.83–0.86) of pooled utility. The pooled utility of asthma declined with worsening control levels and severity. The pooled utility value of EQ-5D-3L was 0.72 (95% CI, 0.63–0.80) for uncontrolled, 0.82 (95% CI, 0.75–0.88) for partly controlled, and 0.87 (95% CI, 0.84–0.90) for well-controlled asthma.Conclusion: Our study shows that EQ-5D-3L and EQ-5D-5L are appropriate for economic evaluations in terms of availability and variability of information, respectively. Asthma patients had poorer utility values with worsened severity and level of asthma control. This study will be useful for health economists conducting economic evaluations of asthma treatments.

show abstract

Section: Discussionmentioning

confidence: 99%